HeartSciences is advancing the field of electrocardiography through the application of wavelet signal processing and artificial intelligence to develop next-generation ECG technology. Wavelet signal processing is currently used in many different industries as an important tool to provide insights and new valuable data related to spectral analysis of a signal. HeartSciences’ MyoVista wavECG Cardiac Testing Device is a 12-lead resting electrocardiograph utilizing continuous wavelet transform (CWT) based signal processing. Patented informatics focus on energy-related information rather than conventional voltage-based information. HeartSciences' mission is to enable accurate, affordable screening for the early detection of heart disease.
Total Funding: $28,198,000
Funding Stage: Funded
Business Stage: Scaling Up
Market: B2B2C, B2B
Company Size: 51 to 100
Founded: 2008
For AI Startup Founders
Get introduced to VC/PE/CVC investors
For Investors at VC/PE firms
Get introduced to AI Startup founders or founders at HeartSciences
HeartSciences - AI Startup | AI Startup Profile Powered by Appengine AI | Appengine AI - AI Ecosystem of 12,000+ AI Startups
HeartSciences - Manage Profile
World's Most Promising AI Startups
World's Leading AI Ecosystem of AI Startups, Founders, Investors, and AI Professionals
Get Started